Publications by the Consortium

• Choukrani G, Álvarez Freile J, Wan W, Egri G, Ustyanovska Avtenyuk N, Wiersma VR, Bremer E, Dähne L.

  Development of vaterite particles for therapeutic protein drug delivery and pH-sensitive release mimicking the tumor microenvironment.

  Particle. 2021.
• Álvarez Freile J, Choukrani G, Zimmermann K, Bremer E, Dähne L.

  Whispering Gallery Modes-based biosensors for real-time monitoring and binding characterization of antibody-based cancer immunotherapeutics.

  Sensors and Actuators B: Chemical. 2021 Nov 346(1):130512.
• Vlaming M, Bilemjian V, Álvarez Freile J, Lourens HJ, van Rooij N, Huls G, van Meerten T, de Bruyn M, Bremer E.

  CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties.

  Sci Rep. 2021 Oct 15;11(1): 20499.
• Kucka K, Lang I, Zhang T, Siegmund D, Medler J, Wajant H.

  Membrane lymphotoxin-beta is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist. Cell

  Death Dis. 2021 Apr 6;12(4):360.
• Aido A, Zaitseva O, Wajant H, Buzgo M, Simaite A.

  Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism.

  Pharmaceutics. 2021 Jul 13;13(7):1072.
• Ustyanovska Avtenyuk N, Choukrani G, Ammatuna E, Niki T, Cendrowicz Król E, Lourens HJ, Huls G, Wiersma VR, Bremer E.

  Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity.

  Biomedicines. 2022, 10(1), 66;
• Medler J, Kucka K, Melo Galegos V, Zhang T, von Rotenhan S, Ulrich J, Bremer E, Hudecek M, Beilhack A, Wajant H. (2021).

  CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism.

  Theranostics. 2022; 12(4):1486-1499.
• Cendrowicz E, Jacob L, Greenwald S, Tamir A, Pecker I, Tabakman R, Ghantous L, Tamir L, Kahn R, Avichzer J, Aronin A, Amsili S, Zorde-Khvalevsky E, Gozlan Y, Vlaming M, Huls G, van Meerten T, Elhalel Dranitzki M, Foley-Comer A, Pereg Y, Peled A, Chajut A, Bremer E.

  DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.

  Journal of Experimental and Clinical Research (in press).
• Freile JA, Choukrani G, Bremer E, Daehne L.

  Facing the Challenges of Pharmaceutical Research Using Whispering Gallery Modes-Based Biosensors.

  American Journal of Biomedical Science & Research. 2020 Mar 8(2).
• Choukrani G, Freile JA, Bremer E, Daehne L.

  Using Nanomedicine to Drive Advances in Cancer Immunotherapy: A Mini Review.

  American Journal of Biomedical Science & Research. 2020 Mar 8(2).
• Avtenyuk Ustyanovska N, Visser N, Bremer E, Wiersma VR.

  The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.

  International Journal of Molecular Sciences. 2020, 21(21), 7820.